CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);INSTITUT CURIE;UNIVERSITE DE MONTPELLIER
发明人:
TAZI, JAMAL,MAHUTEAU-BETZER, FLORENCE,ROUX, PIERRE,GRIERSON, DAVID
申请号：
CA2946329
公开号：
CA2946329C
申请日:
2009.01.12
申请国别(地区):
CA
年份:
2020
代理人:
摘要：
The present invention relates to a compound of oneof the formulas I to XXI； a pharmaceutical compositioncomprising at least one such compound； and the use ofat least one such compound in preparing a drug totreat, in a subject, a genetic disease resulting fromat least one splicing anomaly.
